Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 2/20 | 0.38 |
| ▸ | BTK | Q06187 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18949792 | 0.81 | BACE1 (0.36) | JAK2BTKCYP3A4ALDH1A1THRB | |
| SCHEMBL31256339 | 0.80 | ALDH1A1 (0.32) | CYP3A4ALDH1A1THRB | |
| SCHEMBL24885823 | 0.79 | TSHR (0.33) | CA1CA2CA9 | |
| SCHEMBL24457832 | 0.79 | JAK2 (0.35) | JAK2BTKEGFR | |
| SCHEMBL26694809 | 0.79 | JAK2 (0.30) | JAK2BTKALDH1A1 | |
| SCHEMBL12502203 | 0.78 | CYP3A4 (0.39) | CYP3A4ALDH1A1THRBCA1CA2 | |
| SCHEMBL24616237 | 0.78 | LIPE (0.31) | CYP3A4ALDH1A1CA1CA2CA9 | |
| SCHEMBL30520493 | 0.78 | LIPE (0.31) | CYP3A4ALDH1A1CA1CA2CA9 | |
| SCHEMBL12092027 | 0.77 | LPL (0.30) | — | |
| SCHEMBL12481678 | 0.77 | CYP3A4 (0.42) | JAK2BTKCYP3A4ALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059040-A1 | MUTANT KRAS MODULATORS AND USES THEREOF | NEWAVE PHARMACEUTICAL INC. (US) | 2025-03-20 | — | — | WO | disclosed |
| EP-4399210-A1 | 6-AZA-QUINOLINE DERIVATIVES AND RELATED USES | Black Diamond Therapeutics, Inc. (US) | 2024-07-17 | — | — | EP | disclosed |
| WO-2023039505-A1 | 6-AZA-QUINOLINE DERIVATIVES AND RELATED USES | BLACK DIAMOND THERAPEUTICS, INC. (US) | 2023-03-16 | — | — | WO | disclosed |